Use of Alendronate Sodium (Fosamax) to Ameliorate Osteoporosis in Renal Transplant Patients: A Case-Control Study

Open Access

Peer-reviewed

Research Article

Wen-Hung Huang,

Affiliations Department of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan, Republic of China, Chang Gung University College of Medicine, Taoyuan, Taiwan, Republic of China
⨯
Shen-Yang Lee,

Affiliations Department of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan, Republic of China, Chang Gung University College of Medicine, Taoyuan, Taiwan, Republic of China
⨯
Cheng-Hao Weng,

Affiliations Department of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan, Republic of China, Chang Gung University College of Medicine, Taoyuan, Taiwan, Republic of China
⨯
Ping-Chin Lai

* E-mail: williammaxima@gmail.com

Affiliations Department of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan, Republic of China, Chang Gung University College of Medicine, Taoyuan, Taiwan, Republic of China
⨯

Reader Comments (0)

Osteoporosis
Is the Subject Area "Osteoporosis" applicable to this article?

Thanks for your feedback.
Bone density
Is the Subject Area "Bone density" applicable to this article?

Thanks for your feedback.
Renal transplantation
Is the Subject Area "Renal transplantation" applicable to this article?

Thanks for your feedback.
Immunosuppressives
Is the Subject Area "Immunosuppressives" applicable to this article?

Thanks for your feedback.
Hip
Is the Subject Area "Hip" applicable to this article?

Thanks for your feedback.
Osteopenia and osteoporosis
Is the Subject Area "Osteopenia and osteoporosis" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Steroids
Is the Subject Area "Steroids" applicable to this article?

Thanks for your feedback.